Histone H3 lysine 27 trimethylation, which was downregulated by Enhancer of Zeste Homolog 2 (EZH2), has been identified as a key role in the invasive/mesenchymal regulators of NRAS mutation melanoma [307, 308]. This evidence concerns the gene EZH2 and melanoma.